Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
46.46
0.39 (0.85%)
At close: Aug 15, 2025, 3:59 PM
46.91
0.96%
After-hours: Aug 15, 2025, 07:34 PM EDT
Avidity Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -157.31M | -115.77M | -102.26M | -80.4M | -70.79M | -68.86M | -60.44M | -52.36M | -47.02M | -52.39M | -50.47M | -43.6M | -45.69M | -34.23M | -38.54M | -29.27M | -26.35M | -23.84M |
Depreciation & Amortization | -7.82M | 785K | 738K | 710K | 687K | 641K | 615K | 566K | 529K | 391K | 381K | 370K | 322K | 314K | 208K | 176K | 147K | 108K |
Stock-Based Compensation | 17.66M | 17.74M | 14.15M | 14.09M | 12.81M | 10.31M | 9.85M | 9.82M | 9.45M | 9.1M | 7.31M | 7.09M | 6.51M | 6.24M | 4.52M | 4.55M | 4.29M | 3.7M |
Other Working Capital | -68.84M | -7.9M | -26.62M | -2.67M | -7.53M | -12.91M | 66.54M | 7.18M | -8.68M | -5.68M | -13.92M | -1.22M | -1.08M | -7.01M | 1.46M | 3.75M | -6.25M | -2.06M |
Other Non-Cash Items | 5.98M | -4.33M | -6.34M | -6.03M | -3.65M | -2.13M | 6.3M | 734K | 732K | -1.54M | -799K | -39K | 690K | 164K | 92K | 18K | 29K | 24K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -8.72M | -2.97M | -2.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -58.17M | -23.24M | -6.16M | 6M | -4.06M | -10.34M | 68.9M | 7.41M | -10.66M | -4.53M | 4.39M | 4.22M | 2.56M | -2.06M | 7.51M | 3.75M | -6.25M | 330K |
Operating Cash Flow | -199.67M | -124.83M | -99.87M | -65.61M | -65M | -70.38M | 16.5M | -36.79M | -49.81M | -48.97M | -39.19M | -31.96M | -35.55M | -29.57M | -26.21M | -20.78M | -28.14M | -19.68M |
Capital Expenditures | -3.34M | -3.75M | -3.92M | -1.7M | -531K | -915K | -863K | -923K | -622K | -1.82M | -850K | 107K | -1.32M | -758K | -1.71M | -800K | -708K | -525K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -51.9M | 30.56M | -46.67M | 193.86M | 21.52M | -10.82M | n/a | n/a | 7.3M | n/a | n/a | n/a |
Purchase of Investments | -74M | -169.27M | -297M | -622.43M | -372.54M | -141.56M | -53.81M | -131.79M | -24.05M | -251.35M | -89.65M | -53.63M | -37.85M | -174.72M | -85.36M | n/a | n/a | n/a |
Sales Maturities Of Investments | 262.83M | 330.21M | 236.75M | 141.72M | 98.2M | 109.72M | 105.71M | 101.23M | 70.72M | 57.49M | 82.73M | 64.45M | 21.52M | n/a | 3M | n/a | 3.58M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 51.9M | -30.56M | 46.67M | -193.86M | -21.52M | 10.82M | -16.32M | -174.72M | -7.3M | n/a | 3.58M | n/a |
Investing Cash Flow | 185.49M | 157.19M | -64.17M | -482.41M | -274.87M | -32.75M | 51.04M | -31.48M | 46.05M | -195.68M | -7.77M | 10.93M | -17.64M | -175.47M | -84.06M | -800K | 2.87M | -525K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 155.62M | -122.69M | 13.68M | 145.2M | n/a | n/a | 866K | 520K | 3.72M | 303K | 503K | 10K | 375K | -10.43M | 413K | 17K |
Financial Cash Flow | 3.77M | 1.94M | 13.72M | 342.46M | 446.72M | 389.44M | 31.89M | 40K | 38.97M | 22.96M | 243.65M | 39.62M | 38.78M | 24.11M | 20.71M | 155.17M | 413K | 17K |
Net Cash Flow | -10.29M | 34.34M | -150.32M | -205.56M | 106.85M | 286.32M | 99.43M | -68.23M | 35.21M | -221.69M | 196.7M | 18.59M | -14.41M | -180.94M | -89.56M | 133.59M | -24.85M | -20.19M |
Free Cash Flow | -203.01M | -128.58M | -103.79M | -67.32M | -65.53M | -71.3M | 15.64M | -37.71M | -50.43M | -50.79M | -40.04M | -31.85M | -36.87M | -30.33M | -27.92M | -21.58M | -28.84M | -20.21M |